Panitumumab 400mg/20ml solution for infusion vials
NHS hospitals in England used £17,033,793 of indicative cost of Panitumumab 400mg/20ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 11.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Panitumumab 400mg/20ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Panitumumab 400mg/20ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £1,704,890 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,315,529 |
| Sheffield Teaching Hospitals Nhs Trust | £1,014,904 |
| Royal Surrey County Hosp Nhs Found Trust | £718,299 |
| Blackpool Teaching Hosp Nhs Found Trust | £676,653 |
| East Kent Hospitals University Nhs Ft | £609,898 |
| Great Western Hpl Nhs Foundation Trust | £550,881 |
| Portsmouth Hospitals Nhs Trust | £446,424 |
| The Royal Marsden Nhs Foundation Trust | £441,494 |
| Northumbria H/Care Nhs Foundation Trust | £432,391 |
The primary-care picture
Panitumumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Panitumumab medicine page.